Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits. Issue 12 (22nd September 2017)
- Record Type:
- Journal Article
- Title:
- Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits. Issue 12 (22nd September 2017)
- Main Title:
- Hyperuricemia is Associated with Increased Apo AI Fractional Catabolic Rates and Dysfunctional HDL in New Zealand Rabbits
- Authors:
- Martínez‐Ramírez, Miriam
Flores‐Castillo, Cristóbal
Sánchez‐Lozada, L. Gabriela
Bautista‐Pérez, Rocío
Carreón‐Torres, Elizabeth
Fragoso, José Manuel
Rodriguez‐Pérez, José Manuel
García‐Arroyo, Fernando E.
López‐Olmos, Victoria
Luna‐Luna, María
Vargas‐Alarcón, Gilberto
Franco, Martha
Pérez‐Méndez, Oscar - Abstract:
- Abstract: The potential cause–effect relationship between uric acid plasma concentrations and HDL functionality remains elusive. Therefore, this study aimed to explore the effect of oxonic acid (OA)‐induced hyperuricemia on the HDL size distribution, lipid content of HDL subclasses, and apo AI turnover, as well as HDL functionality in New Zealand white rabbits. Experimental animals received OA 750 mg/kg/day by oral gavage during 21 days. The HDL‐apo AI fractional catabolic rate (FCR) was determined by exogenous labeling with 125 I, and HDL subclasses were determined by sequential ultracentrifugation and PAGE. Paraoxonase‐1 activity (PON‐1) and the effect of HDL on relaxation of aorta rings in vitro were determined as an indication of HDL functionality. Oxonic acid induced a sixfold increase of uricemia (0.84 ± 0.06 vs . 5.24 ± 0.12 mg/dL, P < 0.001), and significant decreases of triglycerides and phospholipids of HDL subclasses, whereas HDL size distribution and HDL‐cholesterol remained unchanged. In addition, HDL‐apo AI FCR was significantly higher in hyperuricemic rabbits than in the control group (0.03697 ± 0.0038 vs . 0.02605 ± 0.0017 h −1 respectively, P < 0.05). Such structural and metabolic changes were associated with lower levels of PON‐1 activities and deleterious effects of HDL particles on endothelium‐mediated vasodilation. In conclusion, hyperuricemia is associated with structural and metabolic modifications of HDL that result in impaired functionality of theseAbstract: The potential cause–effect relationship between uric acid plasma concentrations and HDL functionality remains elusive. Therefore, this study aimed to explore the effect of oxonic acid (OA)‐induced hyperuricemia on the HDL size distribution, lipid content of HDL subclasses, and apo AI turnover, as well as HDL functionality in New Zealand white rabbits. Experimental animals received OA 750 mg/kg/day by oral gavage during 21 days. The HDL‐apo AI fractional catabolic rate (FCR) was determined by exogenous labeling with 125 I, and HDL subclasses were determined by sequential ultracentrifugation and PAGE. Paraoxonase‐1 activity (PON‐1) and the effect of HDL on relaxation of aorta rings in vitro were determined as an indication of HDL functionality. Oxonic acid induced a sixfold increase of uricemia (0.84 ± 0.06 vs . 5.24 ± 0.12 mg/dL, P < 0.001), and significant decreases of triglycerides and phospholipids of HDL subclasses, whereas HDL size distribution and HDL‐cholesterol remained unchanged. In addition, HDL‐apo AI FCR was significantly higher in hyperuricemic rabbits than in the control group (0.03697 ± 0.0038 vs . 0.02605 ± 0.0017 h −1 respectively, P < 0.05). Such structural and metabolic changes were associated with lower levels of PON‐1 activities and deleterious effects of HDL particles on endothelium‐mediated vasodilation. In conclusion, hyperuricemia is associated with structural and metabolic modifications of HDL that result in impaired functionality of these lipoproteins. Our data strongly suggest that uric acid per se exerts deleterious effects on HDL that contribute to increase the risk of atherosclerosis. … (more)
- Is Part Of:
- Lipids. Volume 52:Issue 12(2017)
- Journal:
- Lipids
- Issue:
- Volume 52:Issue 12(2017)
- Issue Display:
- Volume 52, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 52
- Issue:
- 12
- Issue Sort Value:
- 2017-0052-0012-0000
- Page Start:
- 999
- Page End:
- 1006
- Publication Date:
- 2017-09-22
- Subjects:
- Lipoprotein metabolism -- Renal failure -- Coronary heart disease -- Risk factors -- Uricemia
Lipids -- Periodicals
Lipids -- Periodicals
Lipiden
Lipides -- Périodiques
547.77 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0024-4201;screen=info;ECOIP ↗
http://link.springer.com/journal/11745 ↗
http://springerlink.metapress.com/content/120379/?p=67eb9addeb9a4d2a87ce760fbdd684eb&pi=0 ↗
http://www.springerlink.com/content/120379/ ↗
http://www.springer.com/gb/ ↗
http://www.aocs.org/press/ ↗ - DOI:
- 10.1007/s11745-017-4301-y ↗
- Languages:
- English
- ISSNs:
- 0024-4201
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5221.850000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 9936.xml